[VIEW] agent=Quality & Reliability Lead | scenario_id=41 | rounds=20

--- Round 0 ---
[R0.1] Quality & Reliability Lead (speak, public): To decide the least disruptive containment path for the suspected counterfeit microelectronics lot, I need clarity on external reporting timelines, realistic supply continuity paths, and how much schedule buffer exists. Can we start by discussing the current inventory position and potential supply continuity options?
[R0.2] Supply Chain Risk Officer (speak, public): We have an authorized source that can supply 200 units in 10 weeks, or 6 weeks with a 12% premium for expedite. Our corporate policy triggers a stop-ship when counterfeit likelihood exceeds 0.30 pending verification testing. We also need to report suspected counterfeit within 60 days under DFARS 252.246-7007.
[R0.3] Program Finance & Schedule Analyst (speak, public): We have 17 calendar days of float to the next customer delivery gate on June 30, 2026. Given the authorized source can supply 200 units in 10 weeks or 6 weeks with a premium, we need to weigh the risks of not meeting our delivery commitment against the cost implications of expediting or stopping production.

--- Round 1 ---
[R1.1] Quality & Reliability Lead (speak, public): Let's analyze the information shared. We have a 28% failure rate in the sampled units, indicating a high likelihood of counterfeit parts. Given our internal counterfeit control baseline is aligned with AS5553, which recommends quarantine and notification within 24 hours, we should consider quarantining the units. With 17 calendar days to the next customer delivery gate and the possibility of getting 200 units in 6 weeks with a premium, we need to weigh our options carefully. What are the implications of quarantining all 180 units today versus 100% screening in 10 business days?
[R1.2] Supply Chain Risk Officer (speak, public): We've identified chain-of-custody anomalies with the current lot, including gaps in custody signatures and a significant portion sourced via a Tier-2 independent broker. Given these red flags and the indicative counterfeit marker observations, we should consider the likelihood of counterfeit parts to be high. Let's discuss the implications of quarantining versus 100% screening and how it aligns with our corporate policy and DFARS reporting requirements.
[R1.3] Program Finance & Schedule Analyst (speak, public): To assess the financial implications, I need to understand the timeline for 100% screening and the associated costs versus quarantining all 180 units immediately. Additionally, what's the probability of counterfeit parts being confirmed after verification testing?

--- Round 2 ---
[R2.1] Quality & Reliability Lead (speak, public): To assess our options, let's first evaluate the feasibility of 100% screening within 10 business days. We have 2 machines available in-house with an X-ray throughput of 12 units/hour per machine. Given we have 180 units, the total screening time would be approximately 7.5 hours per machine, so with 2 machines, we can complete this within a day. However, we need to consider the labor costs and potential risks associated with screening. On the other hand, quarantining all 180 units today aligns with our internal counterfeit control baseline and corporate policy. We should also discuss the probability of counterfeit parts being confirmed after verification testing and the associated risks.
[R2.2] Supply Chain Risk Officer (speak, public): Let's evaluate our options based on the information gathered. We have a high likelihood of counterfeit parts due to the chain-of-custody anomalies and indicative counterfeit marker observations. 100% screening is feasible within a day, but quarantining all 180 units today aligns with our corporate policy and internal counterfeit control baseline. Given our policy triggers a stop-ship when counterfeit likelihood exceeds 0.30, and we have a 28% failure rate, we should consider quarantining. We need to weigh this against the schedule and financial implications.
[R2.3] Program Finance & Schedule Analyst (speak, public): Let's summarize our findings and assess the financial implications. We have 17 calendar days to the next customer delivery gate. Quarantining aligns with our corporate policy given the high likelihood of counterfeit parts. However, we need to consider the cost of idle labor, potential liquidated damages, and the cost of expedited supply chain options. I recommend we weigh these factors against the schedule buffer and make a decision that balances quality risk and financial exposure.

--- Round 3 ---
[R3.1] Quality & Reliability Lead (speak, public): Let's summarize our discussion and make a decision. We have a high likelihood of counterfeit parts with a 28% failure rate in the sampled units. Quarantining all 180 units today aligns with our internal counterfeit control baseline and corporate policy. We have 17 calendar days to the next customer delivery gate, and an authorized source can supply 200 units in 6 weeks with a premium. Given these factors, I recommend we quarantine all 180 units today to mitigate quality risk, and then proceed with 100% screening to further verify the counterfeit parts. This approach balances our quality risk with the schedule and financial implications.
[R3.2] Supply Chain Risk Officer (speak, public): I agree with quarantining all 180 units today to mitigate quality risk, as it aligns with our corporate policy and internal counterfeit control baseline. Given the high likelihood of counterfeit parts and the potential risks, this is the most prudent course of action. We should proceed with 100% screening to further verify the counterfeit parts and then assess the financial implications of our decision, including the cost of expedited supply chain options and potential liquidated damages.
[R3.3] Program Finance & Schedule Analyst (speak, public): I agree with the recommendation to quarantine all 180 units today to mitigate quality risk, as it aligns with our corporate policy and internal counterfeit control baseline. Given our 17 calendar days of float to the next customer delivery gate and the authorized source's ability to supply 200 units in 6 weeks with a premium, we should proceed with quarantining and then conduct 100% screening to further verify the counterfeit parts. Let's assess the financial implications, including the cost of expedited supply chain options and potential liquidated damages, to ensure we're making an informed decision that balances quality risk and financial exposure.

--- Round 4 ---
[R4.1] Quality & Reliability Lead (speak, public): I believe we have reached a consensus. To confirm, we will quarantine all 180 units today to mitigate quality risk, aligning with our corporate policy and internal counterfeit control baseline. We will then proceed with 100% screening to further verify the counterfeit parts. I will draft a formal recommendation and share it with the team. Let's ensure we document our decision and the rationale for future reference.
[R4.2] Supply Chain Risk Officer (speak, public): I believe we have a clear path forward. Let's document our decision to quarantine all 180 units and proceed with 100% screening, along with the rationale and associated risks. I'll work on drafting the formal report and ensure it's shared with the team.
[R4.3] Program Finance & Schedule Analyst (speak, public): I believe we have a clear path forward. Let's document our decision to quarantine all 180 units and proceed with 100% screening, along with the rationale and associated risks. I'll work on assessing the financial implications and ensure our decision is aligned with our cost and schedule commitments.

--- Round 5 ---
[R5.1] Quality & Reliability Lead (leave, public): 
[R5.2] Supply Chain Risk Officer (leave, public): 
[R5.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 6 ---
[R6.1] Quality & Reliability Lead (leave, public): 
[R6.2] Supply Chain Risk Officer (leave, public): 
[R6.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 7 ---
[R7.1] Quality & Reliability Lead (leave, public): 
[R7.2] Supply Chain Risk Officer (leave, public): 
[R7.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 8 ---
[R8.1] Quality & Reliability Lead (leave, public): 
[R8.2] Supply Chain Risk Officer (leave, public): 
[R8.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 9 ---
[R9.1] Quality & Reliability Lead (leave, public): 
[R9.2] Supply Chain Risk Officer (leave, public): 
[R9.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 10 ---
[R10.1] Quality & Reliability Lead (leave, public): 
[R10.2] Supply Chain Risk Officer (leave, public): 
[R10.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 11 ---
[R11.1] Quality & Reliability Lead (leave, public): 
[R11.2] Supply Chain Risk Officer (leave, public): 
[R11.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 12 ---
[R12.1] Quality & Reliability Lead (leave, public): 
[R12.2] Supply Chain Risk Officer (leave, public): 
[R12.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 13 ---
[R13.1] Quality & Reliability Lead (leave, public): 
[R13.2] Supply Chain Risk Officer (leave, public): 
[R13.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 14 ---
[R14.1] Quality & Reliability Lead (leave, public): 
[R14.2] Supply Chain Risk Officer (leave, public): 
[R14.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 15 ---
[R15.1] Quality & Reliability Lead (leave, public): 
[R15.2] Supply Chain Risk Officer (leave, public): 
[R15.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 16 ---
[R16.1] Quality & Reliability Lead (leave, public): 
[R16.2] Supply Chain Risk Officer (leave, public): 
[R16.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 17 ---
[R17.1] Quality & Reliability Lead (leave, public): 
[R17.2] Supply Chain Risk Officer (leave, public): 
[R17.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 18 ---
[R18.1] Quality & Reliability Lead (leave, public): 
[R18.2] Supply Chain Risk Officer (leave, public): 
[R18.3] Program Finance & Schedule Analyst (leave, public): 

--- Round 19 ---
[R19.1] Quality & Reliability Lead (leave, public): 
[R19.2] Supply Chain Risk Officer (leave, public): 
[R19.3] Program Finance & Schedule Analyst (leave, public): 

